Press Releases
January 12, 2026
European Wax Center, Inc. Provides Update Ahead of the 2026 ICR Conference
Indeterminate
GlobeNewswire, Inc.
January 12, 2026
Women’s Health Market is expected to generate a revenue of USD 65.23 Billion by 2031, Globally, at 5.3% CAGR: Verified Market Research®
Indeterminate
GlobeNewswire, Inc.
January 12, 2026
Biogen Receives European Commission Approval for High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy
Indeterminate
GlobeNewswire, Inc.
January 12, 2026
VIVUS Shares Progress on Pipeline and Key Program Milestones During the 44th Annual J.P. Morgan Healthcare Conference
Indeterminate
GlobeNewswire, Inc.
January 12, 2026
E-Prescription Market Expands to USD 53.17 Billion at 26.84% CAGR by 2034, Driven by Digital Healthcare Adoption
Indeterminate
GlobeNewswire, Inc.
January 12, 2026
Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference
Indeterminate
GlobeNewswire, Inc.
January 12, 2026
MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference
Indeterminate
GlobeNewswire, Inc.
January 12, 2026
Sotera Health to Showcase Continued Revenue Growth and Strategic Value Creation at 44th Annual J.P. Morgan Healthcare Conference
Indeterminate
GlobeNewswire, Inc.
January 12, 2026
Apellis Highlights Commercial Execution and Strategic Priorities at the 44th Annual J.P. Morgan Healthcare Conference
Indeterminate
GlobeNewswire, Inc.
January 12, 2026
Syndax Reports Preliminary 2025 Financial Highlights and Provides Business Updates at the 44th Annual J.P. Morgan Healthcare Conference
Indeterminate
GlobeNewswire, Inc.
January 12, 2026
BioNTech Provides Strategic Business Update and Outlines 2026 Areas of Focus at 44th Annual J.P. Morgan Healthcare Conference
Indeterminate
GlobeNewswire, Inc.
January 12, 2026
Press Release: Sanofi’s Teizeild approved in the EU for patients with stage 2 type 1 diabetes
Indeterminate
GlobeNewswire, Inc.
January 11, 2026
Esperion Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference
Indeterminate
GlobeNewswire, Inc.
January 11, 2026
Molecular Partners Highlights Clinical Development Progress and Anticipated Milestones at 44th Annual J.P. Morgan Healthcare Conference
Indeterminate
GlobeNewswire, Inc.
January 11, 2026
Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference
Indeterminate
GlobeNewswire, Inc.
